Biotechnology
The Biotechnology industry has a total of 639 stocks, with a combined market cap of $853.93 billion and total revenue of $97.87 billion.
Market Cap
853.93B
Revenue
97.87B
Profits
-44.71B
PE Ratio
n/a
Profit Margin
-45.68%
Dividend Yield
0.05%
639 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 120.99B | -1.75% | 272,859 | 11.10B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 59.66B | 0.86% | 177,538 | 14.09B |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 41.38B | -1.64% | 341,971 | 2.35B |
| 4 | ARGX | argenx SE | 34.72B | 0.10% | 108,445 | 2.64B |
| 5 | ONC | BeOne Medicines Ltd. | 29.85B | -0.54% | 82,998 | 4.18B |
| 6 | BNTX | BioNTech SE | 27.84B | -0.76% | 181,722 | 2.97B |
| 7 | RPRX | Royalty Pharma plc | 20.16B | -0.75% | 305,670 | 2.26B |
| 8 | SMMT | Summit Therapeutics Inc. | 18.90B | -1.66% | 696,790 | - |
| 9 | INSM | Insmed Incorporated | 18.77B | 2.20% | 800,414 | 381.03M |
| 10 | GMAB | Genmab A/S | 13.43B | -1.37% | 391,056 | 3.23B |
| 11 | INCY | Incyte Corporation | 13.36B | -1.88% | 235,746 | 4.41B |
| 12 | MRNA | Moderna, Inc. | 13.01B | -1.90% | 3,141,174 | 3.18B |
| 13 | EXEL | Exelixis, Inc. | 12.32B | 0.02% | 363,787 | 2.30B |
| 14 | BMRN | BioMarin Pharmaceutical Inc. | 11.12B | -1.39% | 506,904 | 2.95B |
| 15 | ASND | Ascendis Pharma A/S | 10.62B | -0.65% | 125,511 | 398.51M |
| 16 | VRNA | Verona Pharma plc | 9.56B | - | 7,085,043 | 118.54M |
| 17 | BBIO | BridgeBio Pharma, Inc. | 8.77B | -0.15% | 470,929 | 127.42M |
| 18 | TECH | Bio-Techne Corporation | 8.42B | -1.23% | 236,466 | 1.21B |
| 19 | BPMC | Blueprint Medicines Corporation | 8.37B | -0.02% | 1,555,045 | 562.12M |
| 20 | ROIV | Roivant Sciences Ltd. | 7.77B | -1.21% | 1,088,193 | 29.05M |
| 21 | CORT | Corcept Therapeutics Incorporated | 7.48B | -2.01% | 127,944 | 685.45M |
| 22 | CAI | Caris Life Sciences, Inc. | 7.36B | -0.49% | 110,713 | 452.50M |
| 23 | LEGN | Legend Biotech Corporation | 7.24B | -1.11% | 237,195 | 728.30M |
| 24 | RVMD | Revolution Medicines, Inc. | 7.12B | -0.75% | 249,424 | - |
| 25 | HALO | Halozyme Therapeutics, Inc. | 7.02B | -1.08% | 259,396 | 1.08B |
| 26 | MDGL | Madrigal Pharmaceuticals, Inc. | 6.97B | -0.16% | 40,933 | 317.38M |
| 27 | JAZZ | Jazz Pharmaceuticals plc | 6.69B | -1.64% | 70,565 | 4.06B |
| 28 | IONS | Ionis Pharmaceuticals, Inc. | 6.66B | -1.23% | 280,678 | 717.25M |
| 29 | NUVL | Nuvalent, Inc. | 5.89B | -0.10% | 49,386 | - |
| 30 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.63B | -0.55% | 301,548 | 136.86M |
| 31 | AXSM | Axsome Therapeutics, Inc. | 5.49B | 0.47% | 270,273 | 432.16M |
| 32 | TGTX | TG Therapeutics, Inc. | 5.46B | -0.53% | 234,677 | 386.39M |
| 33 | TLX | Telix Pharmaceuticals Limited | 5.35B | -2.36% | 4,369 | 484.69M |
| 34 | CRSP | CRISPR Therapeutics AG | 5.27B | -2.71% | 1,142,395 | 37.68M |
| 35 | PCVX | Vaxcyte, Inc. | 4.64B | -0.72% | 682,724 | - |
| 36 | CYTK | Cytokinetics, Incorporated | 4.40B | 0.71% | 219,143 | 19.22M |
| 37 | ADMA | ADMA Biologics, Inc. | 4.37B | -0.97% | 587,826 | 459.38M |
| 38 | KRYS | Krystal Biotech, Inc. | 4.29B | -0.89% | 69,642 | 333.45M |
| 39 | SLNO | Soleno Therapeutics, Inc. | 4.16B | 2.68% | 855,581 | - |
| 40 | AKRO | Akero Therapeutics, Inc. | 4.13B | -0.42% | 179,447 | - |
| 41 | MRUS | Merus N.V. | 4.10B | -0.09% | 79,431 | 54.73M |
| 42 | MTSR | Metsera, Inc. | 3.95B | 3.32% | 128,721 | - |
| 43 | RNA | Avidity Biosciences, Inc. | 3.89B | 2.45% | 1,657,946 | 8.93M |
| 44 | PTCT | PTC Therapeutics, Inc. | 3.86B | -1.53% | 153,759 | 1.77B |
| 45 | ACLX | Arcellx, Inc. | 3.76B | -0.86% | 36,932 | 76.81M |
| 46 | ZLAB | Zai Lab Limited | 3.63B | -3.81% | 222,005 | 418.33M |
| 47 | ACAD | ACADIA Pharmaceuticals Inc. | 3.62B | -1.95% | 752,731 | 996.28M |
| 48 | SRRK | Scholar Rock Holding Corporation | 3.58B | -1.09% | 129,622 | - |
| 49 | VKTX | Viking Therapeutics, Inc. | 3.45B | -1.69% | 954,697 | - |
| 50 | AAPG | Ascentage Pharma Group International | 3.34B | -5.20% | 1,521 | 134.35M |
| 51 | PTGX | Protagonist Therapeutics, Inc. | 3.32B | 1.37% | 120,749 | 207.80M |
| 52 | KYMR | Kymera Therapeutics, Inc. | 3.13B | -1.42% | 141,536 | 58.89M |
| 53 | MLTX | MoonLake Immunotherapeutics | 3.13B | 0.74% | 202,462 | - |
| 54 | IMVT | Immunovant, Inc. | 3.07B | 2.51% | 310,396 | - |
| 55 | CRNX | Crinetics Pharmaceuticals, Inc. | 2.97B | -0.97% | 112,424 | 760.00K |
| 56 | RARE | Ultragenyx Pharmaceutical Inc. | 2.86B | -2.21% | 1,865,336 | 590.69M |
| 57 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.63B | -1.14% | 465,969 | 534.65M |
| 58 | MIRM | Mirum Pharmaceuticals, Inc. | 2.63B | 0.25% | 101,575 | 379.25M |
| 59 | ARWR | Arrowhead Pharmaceuticals, Inc. | 2.54B | -2.60% | 327,579 | 545.21M |
| 60 | IBRX | ImmunityBio, Inc. | 2.52B | -0.35% | 2,675,232 | 31.22M |
| 61 | XENE | Xenon Pharmaceuticals Inc. | 2.48B | -1.96% | 97,734 | 7.50M |
| 62 | NAMS | NewAmsterdam Pharma Company N.V. | 2.45B | -1.00% | 210,455 | 47.14M |
| 63 | APLS | Apellis Pharmaceuticals, Inc. | 2.40B | -2.10% | 161,913 | 775.84M |
| 64 | RXRX | Recursion Pharmaceuticals, Inc. | 2.38B | -3.94% | 17,075,127 | 59.79M |
| 65 | AGIO | Agios Pharmaceuticals, Inc. | 2.27B | -0.99% | 232,482 | 37.04M |
| 66 | APGE | Apogee Therapeutics, Inc. | 2.26B | 0.17% | 275,493 | - |
| 67 | DNLI | Denali Therapeutics Inc. | 2.18B | -2.28% | 520,350 | - |
| 68 | BEAM | Beam Therapeutics Inc. | 2.10B | -2.27% | 997,618 | 63.58M |
| 69 | CGON | CG Oncology, Inc. | 2.04B | -1.42% | 104,870 | 662.00K |
| 70 | VCEL | Vericel Corporation | 2.02B | -2.50% | 44,883 | 238.54M |
| 71 | BLTE | Belite Bio, Inc | 2.02B | 0.19% | 45,580 | - |
| 72 | GLPG | Galapagos NV | 2.00B | 0.07% | 38,305 | 311.49M |
| 73 | IDYA | IDEAYA Biosciences, Inc. | 2.00B | 0.09% | 188,657 | 7.00M |
| 74 | IRON | Disc Medicine, Inc. | 1.98B | -1.53% | 115,837 | - |
| 75 | HRMY | Harmony Biosciences Holdings, Inc. | 1.96B | -0.58% | 77,613 | 744.85M |
| 76 | CNTA | Centessa Pharmaceuticals plc | 1.95B | -0.61% | 97,669 | 15.00M |
| 77 | FOLD | Amicus Therapeutics, Inc. | 1.91B | -1.75% | 726,380 | 543.14M |
| 78 | COGT | Cogent Biosciences, Inc. | 1.82B | 2.30% | 818,731 | - |
| 79 | SRPT | Sarepta Therapeutics, Inc. | 1.80B | -3.88% | 1,154,372 | 2.23B |
| 80 | OCUL | Ocular Therapeutix, Inc. | 1.79B | 1.35% | 810,613 | 59.65M |
| 81 | ADPT | Adaptive Biotechnologies Corporation | 1.79B | -2.73% | 532,256 | 189.53M |
| 82 | ARQT | Arcutis Biotherapeutics, Inc. | 1.77B | -2.75% | 377,126 | 212.82M |
| 83 | SPRY | ARS Pharmaceuticals, Inc. | 1.76B | -0.50% | 215,021 | 97.12M |
| 84 | IMCR | Immunocore Holdings plc | 1.76B | -1.44% | 34,148 | 333.58M |
| 85 | TARS | Tarsus Pharmaceuticals, Inc. | 1.68B | -2.70% | 82,176 | 233.67M |
| 86 | ETNB | 89bio, Inc. | 1.57B | -0.19% | 174,394 | - |
| 87 | CLDX | Celldex Therapeutics, Inc. | 1.54B | 2.29% | 349,781 | 7.56M |
| 88 | VERA | Vera Therapeutics, Inc. | 1.54B | -1.15% | 83,733 | - |
| 89 | JANX | Janux Therapeutics, Inc. | 1.51B | -0.23% | 360,626 | 9.34M |
| 90 | PROK | ProKidney Corp. | 1.47B | -2.90% | 10,381,616 | 306.00K |
| 91 | BHVN | Biohaven Ltd. | 1.46B | -4.92% | 281,361 | - |
| 92 | TVTX | Travere Therapeutics, Inc. | 1.46B | -0.85% | 290,180 | 273.53M |
| 93 | EWTX | Edgewise Therapeutics, Inc. | 1.44B | -1.59% | 61,521 | - |
| 94 | VRDN | Viridian Therapeutics, Inc. | 1.40B | - | 91,827 | 302.00K |
| 95 | MESO | Mesoblast Limited | 1.39B | -0.54% | 36,493 | 5.67M |
| 96 | ELVN | Enliven Therapeutics, Inc. | 1.35B | 0.63% | 109,836 | - |
| 97 | ABCL | AbCellera Biologics Inc. | 1.24B | -2.59% | 2,041,693 | 23.11M |
| 98 | DYN | Dyne Therapeutics, Inc. | 1.23B | -1.02% | 1,055,719 | - |
| 99 | CVAC | CureVac N.V. | 1.22B | -0.18% | 729,025 | 566.04M |
| 100 | AUPH | Aurinia Pharmaceuticals Inc. | 1.22B | 1.12% | 474,008 | 247.30M |
| 101 | NTLA | Intellia Therapeutics, Inc. | 1.22B | -3.21% | 1,313,062 | 45.57M |
| 102 | WVE | Wave Life Sciences Ltd. | 1.21B | -1.13% | 370,634 | 104.94M |
| 103 | INVA | Innoviva, Inc. | 1.20B | - | 202,959 | 369.84M |
| 104 | LQDA | Liquidia Corporation | 1.19B | -1.27% | 292,445 | 14.14M |
| 105 | MNKD | MannKind Corporation | 1.15B | -0.79% | 415,883 | 297.60M |
| 106 | PHVS | Pharvaris N.V. | 1.13B | 4.84% | 30,818 | - |
| 107 | NVAX | Novavax, Inc. | 1.12B | -2.82% | 1,884,188 | 1.25B |
| 108 | ARDX | Ardelyx, Inc. | 1.11B | -1.49% | 1,384,633 | 361.71M |
| 109 | GPCR | Structure Therapeutics Inc. | 1.10B | 1.16% | 271,222 | - |
| 110 | CDTX | Cidara Therapeutics, Inc. | 1.08B | -3.69% | 147,165 | 302.00K |
| 111 | PRAX | Praxis Precision Medicines, Inc. | 1.02B | -0.42% | 85,765 | 8.12M |
| 112 | ZYME | Zymeworks Inc. | 1.01B | -1.10% | 136,468 | 93.38M |
| 113 | RCUS | Arcus Biosciences, Inc. | 995.85M | -1.42% | 137,571 | 141.00M |
| 114 | OCS | Oculis Holding AG | 990.88M | -1.25% | 11,276 | 847.33K |
| 115 | VERV | Verve Therapeutics, Inc. | 987.44M | -0.05% | 1,003,828 | 59.61M |
| 116 | MDXG | MiMedx Group, Inc. | 980.74M | -2.06% | 126,788 | 352.38M |
| 117 | NRIX | Nurix Therapeutics, Inc. | 978.55M | 1.03% | 292,606 | 88.38M |
| 118 | LENZ | LENZ Therapeutics, Inc. | 974.14M | 1.02% | 37,883 | - |
| 119 | GHRS | GH Research PLC | 962.06M | -3.36% | 79,564 | - |
| 120 | SYRE | Spyre Therapeutics, Inc. | 950.57M | -1.32% | 45,855 | - |
| 121 | ORIC | ORIC Pharmaceuticals, Inc. | 949.40M | -2.71% | 145,589 | - |
| 122 | MLYS | Mineralys Therapeutics, Inc. | 939.83M | -1.50% | 86,621 | - |
| 123 | SANA | Sana Biotechnology, Inc. | 933.80M | 1.97% | 2,274,342 | - |
| 124 | AVXL | Anavex Life Sciences Corp. | 933.11M | -2.24% | 223,056 | - |
| 125 | NAGE | Niagen Bioscience, Inc. | 903.82M | -2.88% | 244,643 | 107.93M |
| 126 | SION | Sionna Therapeutics, Inc. | 895.07M | -3.06% | 4,796 | - |
| 127 | CRMD | CorMedix Inc. | 844.03M | -3.16% | 443,340 | 82.55M |
| 128 | GERN | Geron Corporation | 843.92M | -3.99% | 1,707,771 | 116.29M |
| 129 | REPL | Replimune Group, Inc. | 836.39M | 0.74% | 978,751 | - |
| 130 | XERS | Xeris Biopharma Holdings, Inc. | 825.60M | -2.18% | 435,028 | 222.55M |
| 131 | SNDX | Syndax Pharmaceuticals, Inc. | 824.76M | -2.39% | 298,581 | 43.72M |
| 132 | QURE | uniQure N.V. | 806.45M | -1.01% | 159,783 | 20.20M |
| 133 | AVBP | ArriVent BioPharma, Inc. | 790.01M | -1.82% | 23,159 | - |
| 134 | VIR | Vir Biotechnology, Inc. | 787.27M | -3.96% | 313,204 | 20.86M |
| 135 | ANAB | AnaptysBio, Inc. | 769.32M | 0.36% | 39,794 | 111.87M |
| 136 | IMNM | Immunome, Inc. | 762.23M | -2.12% | 127,021 | 10.94M |
| 137 | NUVB | Nuvation Bio Inc. | 762.19M | -3.03% | 1,040,578 | 10.96M |
| 138 | TRVI | Trevi Therapeutics, Inc. | 751.80M | -1.56% | 323,869 | - |
| 139 | EYPT | EyePoint Pharmaceuticals, Inc. | 741.45M | -2.58% | 217,995 | 56.04M |
| 140 | IMTX | Immatics N.V. | 739.03M | 1.33% | 151,340 | 155.80M |
| 141 | MRVI | Maravai LifeSciences Holdings, Inc. | 711.77M | -3.29% | 275,913 | 241.86M |
| 142 | DAWN | Day One Biopharmaceuticals, Inc. | 709.54M | -2.64% | 328,660 | 161.92M |
| 143 | PHAR | Pharming Group N.V. | 705.89M | 1.70% | 1,000 | 320.71M |
| 144 | KALV | KalVista Pharmaceuticals, Inc. | 696.67M | -9.74% | 978,520 | - |
| 145 | GYRE | Gyre Therapeutics, Inc. | 687.18M | -2.94% | 26,153 | 100.64M |
| 146 | MGTX | MeiraGTx Holdings plc | 679.09M | -1.97% | 187,023 | 34.51M |
| 147 | MAZE | Maze Therapeutics, Inc. | 670.97M | -2.05% | 45,060 | 167.50M |
| 148 | PHAT | Phathom Pharmaceuticals, Inc. | 664.44M | -1.55% | 243,894 | 81.86M |
| 149 | URGN | UroGen Pharma Ltd. | 660.03M | -2.22% | 221,122 | 91.87M |
| 150 | ZVRA | Zevra Therapeutics, Inc. | 658.89M | 0.25% | 315,660 | 40.59M |
| 151 | DNTH | Dianthus Therapeutics, Inc. | 655.58M | -1.09% | 45,440 | 6.52M |
| 152 | AMLX | Amylyx Pharmaceuticals, Inc. | 655.19M | -0.54% | 281,108 | -1.27M |
| 153 | AUTL | Autolus Therapeutics plc | 654.71M | -0.81% | 317,049 | 9.01M |
| 154 | XNCR | Xencor, Inc. | 649.08M | -1.72% | 46,761 | 127.23M |
| 155 | STOK | Stoke Therapeutics, Inc. | 643.70M | -2.08% | 102,406 | 190.91M |
| 156 | TNGX | Tango Therapeutics, Inc. | 635.19M | -4.09% | 328,579 | 40.99M |
| 157 | IOVA | Iovance Biotherapeutics, Inc. | 634.48M | -1.55% | 2,709,153 | 212.68M |
| 158 | UPB | Upstream Bio, Inc. | 622.39M | -2.28% | 29,576 | 2.30M |
| 159 | RLAY | Relay Therapeutics, Inc. | 619.77M | -3.08% | 227,532 | 7.68M |
| 160 | ABUS | Arbutus Biopharma Corporation | 602.35M | -4.12% | 199,504 | 6.40M |
| 161 | DNA | Ginkgo Bioworks Holdings, Inc. | 597.61M | -5.38% | 582,102 | 237.42M |
| 162 | MNMD | Mind Medicine (MindMed) Inc. | 594.60M | -2.84% | 323,384 | - |
| 163 | KROS | Keros Therapeutics, Inc. | 585.67M | -0.35% | 85,242 | 214.71M |
| 164 | SAGE | Sage Therapeutics, Inc. | 579.57M | 0.49% | 621,604 | 47.40M |
| 165 | ARVN | Arvinas, Inc. | 575.90M | - | 385,305 | 426.90M |
| 166 | TSHA | Taysha Gene Therapies, Inc. | 573.15M | 4.71% | 1,326,758 | 7.22M |
| 167 | ATAI | Atai Life Sciences N.V. | 568.55M | -1.83% | 1,208,826 | 1.86M |
| 168 | TBPH | Theravance Biopharma, Inc. | 566.77M | -1.09% | 10,492 | 65.27M |
| 169 | PRME | Prime Medicine, Inc. | 556.84M | -9.38% | 3,502,541 | 3.85M |
| 170 | BCYC | Bicycle Therapeutics plc | 549.88M | -1.85% | 48,179 | 25.72M |
| 171 | PGEN | Precigen, Inc. | 549.03M | -2.62% | 333,047 | 4.20M |
| 172 | TYRA | Tyra Biosciences, Inc. | 542.42M | -0.39% | 17,412 | - |
| 173 | KURA | Kura Oncology, Inc. | 541.09M | -1.73% | 347,098 | 67.99M |
| 174 | RAPP | Rapport Therapeutics, Inc. | 534.69M | -4.75% | 27,283 | - |
| 175 | ORKA | Oruka Therapeutics, Inc. | 529.78M | 0.57% | 16,430 | - |
| 176 | BCAX | Bicara Therapeutics Inc. | 524.09M | -3.13% | 45,015 | - |
| 177 | ABVX | ABIVAX Société Anonyme | 523.74M | 2.41% | 150,470 | 11.44M |
| 178 | SEPN | Septerna, Inc. | 519.55M | -0.17% | 59,125 | 977.00K |
| 179 | CELC | Celcuity Inc. | 510.06M | -1.10% | 36,164 | - |
| 180 | VALN | Valneva SE | 506.85M | 0.50% | 6,124 | 201.10M |
| 181 | SVRA | Savara Inc. | 503.55M | 3.91% | 367,010 | - |
| 182 | ZBIO | Zenas BioPharma, Inc. | 475.24M | -5.88% | 20,042 | 15.00M |
| 183 | ATYR | aTyr Pharma, Inc. | 469.94M | -0.94% | 1,415,346 | 235.00K |
| 184 | OPT | Opthea Limited | 466.57M | - | - | 208.86K |
| 185 | FTRE | Fortrea Holdings Inc. | 459.04M | -3.80% | 277,524 | 2.69B |
| 186 | CGEM | Cullinan Therapeutics, Inc. | 457.07M | -1.21% | 32,325 | - |
| 187 | IVA | Inventiva S.A. | 450.35M | 0.59% | 17,894 | 14.59M |
| 188 | RGNX | REGENXBIO Inc. | 450.22M | -1.38% | 75,613 | 156.72M |
| 189 | RZLT | Rezolute, Inc. | 449.69M | 0.16% | 88,935 | - |
| 190 | TRML | Tourmaline Bio, Inc. | 445.70M | -0.12% | 20,105 | - |
| 191 | FULC | Fulcrum Therapeutics, Inc. | 438.85M | 1.50% | 142,290 | 80.00M |
| 192 | PRTC | PureTech Health plc | 432.70M | -0.66% | 276 | 4.83M |
| 193 | NKTR | Nektar Therapeutics | 424.74M | -2.19% | 631,104 | 87.25M |
| 194 | TERN | Terns Pharmaceuticals, Inc. | 423.59M | -0.41% | 268,478 | - |
| 195 | ERAS | Erasca, Inc. | 417.85M | -2.96% | 155,150 | - |
| 196 | MBX | MBX Biosciences, Inc. | 416.80M | 0.56% | 91,695 | - |
| 197 | SLDB | Solid Biosciences Inc. | 416.26M | -0.92% | 219,584 | - |
| 198 | AURA | Aura Biosciences, Inc. | 409.85M | -2.36% | 15,053 | - |
| 199 | TECX | Tectonic Therapeutic, Inc. | 396.79M | -2.16% | 57,416 | - |
| 200 | LXRX | Lexicon Pharmaceuticals, Inc. | 394.05M | -3.98% | 1,527,210 | 31.21M |
| 201 | ITOS | iTeos Therapeutics, Inc. | 392.31M | 0.39% | 139,268 | 35.00M |
| 202 | VIGL | Vigil Neuroscience, Inc. | 383.80M | 0.12% | 100,024 | - |
| 203 | ARCT | Arcturus Therapeutics Holdings Inc. | 383.21M | -2.42% | 54,504 | 143.68M |
| 204 | CTMX | CytomX Therapeutics, Inc. | 381.26M | -6.92% | 621,956 | 147.56M |
| 205 | CMPX | Compass Therapeutics, Inc. | 378.89M | -3.86% | 244,224 | 850.00K |
| 206 | ATXS | Astria Therapeutics, Inc. | 367.95M | -2.25% | 57,860 | - |
| 207 | HUMA | Humacyte, Inc. | 366.86M | -5.78% | 2,516,762 | 517.00K |
| 208 | ADCT | ADC Therapeutics SA | 362.44M | -2.12% | 143,779 | 75.82M |
| 209 | CAPR | Capricor Therapeutics, Inc. | 361.09M | -30.70% | 15,054,343 | 17.36M |
| 210 | RNAC | Cartesian Therapeutics, Inc. | 347.01M | -1.26% | 13,942 | 34.17M |
| 211 | PRTA | Prothena Corporation plc | 346.65M | -1.98% | 168,870 | 137.94M |
| 212 | BNTC | Benitec Biopharma Inc. | 345.98M | -4.42% | 7,084 | - |
| 213 | ABSI | Absci Corporation | 341.22M | -2.01% | 1,220,775 | 4.82M |
| 214 | RIGL | Rigel Pharmaceuticals, Inc. | 340.83M | -2.70% | 69,279 | 203.08M |
| 215 | ALT | Altimmune, Inc. | 337.41M | -5.45% | 1,886,451 | 20.00K |
| 216 | HRTX | Heron Therapeutics, Inc. | 336.40M | -0.68% | 238,354 | 148.52M |
| 217 | JBIO | Jade Biosciences, Inc. | 330.74M | -2.47% | 41,503 | - |
| 218 | OCGN | Ocugen, Inc. | 330.00M | -1.74% | 2,220,106 | 4.52M |
| 219 | RCKT | Rocket Pharmaceuticals, Inc. | 329.14M | -3.32% | 531,350 | - |
| 220 | XOMA | XOMA Royalty Corporation | 327.89M | -1.79% | 6,497 | 42.91M |
| 221 | OLMA | Olema Pharmaceuticals, Inc. | 325.00M | -2.06% | 77,636 | - |
| 222 | VOR | Vor Biopharma Inc. | 323.65M | 12.12% | 6,252,381 | - |
| 223 | AVIR | Atea Pharmaceuticals, Inc. | 323.06M | -0.13% | 89,671 | - |
| 224 | GLUE | Monte Rosa Therapeutics, Inc. | 322.00M | -0.48% | 74,946 | 159.49M |
| 225 | CRVS | Corvus Pharmaceuticals, Inc. | 317.33M | -3.18% | 73,074 | - |
| 226 | GOSS | Gossamer Bio, Inc. | 312.54M | 1.10% | 265,721 | 124.59M |
| 227 | NGNE | Neurogene Inc. | 311.34M | -0.59% | 19,278 | 925.00K |
| 228 | SGMT | Sagimet Biosciences Inc. | 310.36M | -2.72% | 456,289 | - |
| 229 | INBX | Inhibrx Biosciences, Inc. | 308.48M | 1.57% | 9,351 | 200.00K |
| 230 | DBVT | DBV Technologies S.A. | 304.94M | 9.18% | 1,067 | 3.50M |
| 231 | SLN | Silence Therapeutics plc | 304.16M | 0.31% | 27,273 | 27.70M |
| 232 | FHTX | Foghorn Therapeutics Inc. | 301.28M | 0.09% | 22,766 | 23.50M |
| 233 | CADL | Candel Therapeutics, Inc. | 299.11M | -2.93% | 309,847 | - |
| 234 | ABEO | Abeona Therapeutics Inc. | 295.17M | -1.37% | 227,689 | - |
| 235 | TNXP | Tonix Pharmaceuticals Holding Corp. | 292.53M | -6.75% | 279,260 | 10.04M |
| 236 | PVLA | Palvella Therapeutics, Inc. | 292.20M | -1.89% | 13,712 | - |
| 237 | ANNX | Annexon, Inc. | 290.74M | -5.36% | 608,174 | - |
| 238 | VNDA | Vanda Pharmaceuticals Inc. | 282.30M | -4.01% | 119,184 | 201.35M |
| 239 | ALLO | Allogene Therapeutics, Inc. | 281.07M | 1.98% | 1,499,915 | 22.00K |
| 240 | ALDX | Aldeyra Therapeutics, Inc. | 277.02M | -3.65% | 862,918 | - |
| 241 | CRDF | Cardiff Oncology, Inc. | 272.76M | -1.44% | 318,272 | 587.00K |
| 242 | AARD | Aardvark Therapeutics, Inc. | 268.60M | -1.75% | 5,653 | - |
| 243 | MREO | Mereo BioPharma Group plc | 263.15M | -2.07% | 3,940,788 | 1.00M |
| 244 | DRTS | Alpha Tau Medical Ltd. | 260.88M | -2.22% | 1,700 | - |
| 245 | NBTX | Nanobiotix S.A. | 256.80M | 2.87% | 435 | -7.44M |
| 246 | CDXS | Codexis, Inc. | 253.92M | -1.45% | 177,981 | 49.82M |
| 247 | VSTM | Verastem, Inc. | 253.32M | -2.74% | 388,765 | 10.00M |
| 248 | PRQR | ProQR Therapeutics N.V. | 246.50M | -0.85% | 101,145 | 21.21M |
| 249 | THRD | Third Harmonic Bio, Inc. | 246.17M | 0.09% | 15,222 | - |
| 250 | FENC | Fennec Pharmaceuticals Inc. | 245.81M | -1.55% | 68,886 | 30.91M |
| 251 | LXEO | Lexeo Therapeutics, Inc. | 241.37M | -2.61% | 47,673 | - |
| 252 | OABI | OmniAb, Inc. | 239.17M | -5.10% | 124,164 | 26.74M |
| 253 | NVCT | Nuvectis Pharma, Inc. | 238.89M | -2.35% | 10,108 | - |
| 254 | SCPH | scPharmaceuticals Inc. | 237.56M | 0.67% | 101,097 | 41.98M |
| 255 | EDIT | Editas Medicine, Inc. | 236.07M | -7.84% | 1,165,850 | 35.84M |
| 256 | TRDA | Entrada Therapeutics, Inc. | 235.16M | -1.33% | 45,488 | 172.22M |
| 257 | KOD | Kodiak Sciences Inc. | 233.68M | -1.11% | 53,265 | - |
| 258 | INKT | MiNK Therapeutics, Inc. | 232.28M | 653.95% | 24,503,123 | - |
| 259 | TENX | Tenax Therapeutics, Inc. | 232.00M | 1.24% | 5,524 | - |
| 260 | IMMP | Immutep Limited | 230.04M | 1.22% | 18,342 | 3.02M |
| 261 | LCTX | Lineage Cell Therapeutics, Inc. | 228.36M | -1.96% | 372,119 | 9.56M |
| 262 | MNPR | Monopar Therapeutics Inc. | 226.04M | -3.39% | 4,331 | - |
| 263 | MDWD | MediWound Ltd. | 225.07M | -1.26% | 3,162 | 19.21M |
| 264 | DSGN | Design Therapeutics, Inc. | 223.67M | -2.48% | 9,331 | - |
| 265 | TVGN | Tevogen Bio Holdings Inc. | 223.18M | -0.82% | 51,214 | - |
| 266 | TVRD | Tvardi Therapeutics, Inc. | 221.95M | 4.59% | 25,174 | - |
| 267 | LRMR | Larimar Therapeutics, Inc. | 216.09M | -3.02% | 248,376 | - |
| 268 | CRGX | CARGO Therapeutics, Inc. | 213.51M | -0.22% | 412,715 | - |
| 269 | OMER | Omeros Corporation | 209.18M | 3.18% | 532,248 | - |
| 270 | ELDN | Eledon Pharmaceuticals, Inc. | 207.79M | 0.58% | 81,767 | - |
| 271 | ACIU | AC Immune SA | 204.81M | -1.90% | 27,494 | 32.01M |
| 272 | EPRX | Eupraxia Pharmaceuticals Inc. | 199.87M | -2.47% | 1,331 | - |
| 273 | CBIO | Crescent Biopharma, Inc. | 198.88M | -1.48% | 65,194 | - |
| 274 | VTYX | Ventyx Biosciences, Inc. | 197.83M | -2.11% | 358,376 | - |
| 275 | YMAB | Y-mAbs Therapeutics, Inc. | 197.72M | -3.43% | 16,441 | 88.66M |
| 276 | FDMT | 4D Molecular Therapeutics, Inc. | 197.57M | -1.95% | 40,517 | 23.00K |
| 277 | VYGR | Voyager Therapeutics, Inc. | 197.00M | 0.28% | 295,964 | 66.96M |
| 278 | GNFT | Genfit S.A. | 192.99M | 0.80% | 1,117 | 73.19M |
| 279 | ALMS | Alumis Inc. | 192.60M | -0.56% | 204,444 | 17.39M |
| 280 | ENGNW | enGene Holdings Inc. | 188.07M | - | 11 | - |
| 281 | SLS | SELLAS Life Sciences Group, Inc. | 184.09M | -2.64% | 887,128 | - |
| 282 | AGEN | Agenus Inc. | 182.05M | 12.16% | 3,018,310 | 99.52M |
| 283 | DRUG | Bright Minds Biosciences Inc. | 180.95M | -3.53% | 3,343 | - |
| 284 | LIMN | Liminatus Pharma, Inc. | 175.60M | -6.25% | 78,896 | - |
| 285 | ENGN | enGene Holdings Inc. | 175.55M | -6.66% | 36,545 | - |
| 286 | NMRA | Neumora Therapeutics, Inc. | 174.69M | 1.89% | 416,347 | - |
| 287 | IMAB | I-Mab | 173.13M | 3.42% | 172,227 | 569.46K |
| 288 | CYBN | Cybin Inc. | 172.52M | -1.45% | 126,022 | - |
| 289 | ACOG | Alpha Cognition Inc. | 171.41M | -2.73% | 3,754 | 2.93M |
| 290 | PBYI | Puma Biotechnology, Inc. | 170.51M | -2.41% | 74,836 | 232.71M |
| 291 | ACRS | Aclaris Therapeutics, Inc. | 168.38M | -2.20% | 193,007 | 17.78M |
| 292 | KYTX | Kyverna Therapeutics, Inc. | 165.53M | 7.28% | 386,202 | - |
| 293 | CCCC | C4 Therapeutics, Inc. | 165.45M | 17.09% | 2,048,499 | 39.78M |
| 294 | ALEC | Alector, Inc. | 163.99M | -4.65% | 60,434 | 88.34M |
| 295 | TLSA | Tiziana Life Sciences Ltd | 163.85M | - | 75,399 | - |
| 296 | IPHA | Innate Pharma S.A. | 162.87M | - | 3,225 | 20.83M |
| 297 | TIL | Instil Bio, Inc. | 161.83M | -7.81% | 64,307 | - |
| 298 | GALT | Galectin Therapeutics Inc. | 158.23M | 2.04% | 213,530 | - |
| 299 | CABA | Cabaletta Bio, Inc. | 157.40M | 0.57% | 250,490 | - |
| 300 | SPRO | Spero Therapeutics, Inc. | 157.39M | -0.88% | 424,245 | 44.58M |
| 301 | BDTX | Black Diamond Therapeutics, Inc. | 156.94M | 0.73% | 284,280 | 70.00M |
| 302 | CRBU | Caribou Biosciences, Inc. | 154.85M | -4.31% | 529,996 | 9.92M |
| 303 | DMAC | DiaMedica Therapeutics Inc. | 153.95M | -2.18% | 24,245 | - |
| 304 | CGEN | Compugen Ltd. | 151.96M | -3.85% | 153,105 | 27.59M |
| 305 | IMRX | Immuneering Corporation | 151.50M | -2.77% | 377,600 | - |
| 306 | GLSI | Greenwich LifeSciences, Inc. | 147.05M | -1.96% | 26,866 | - |
| 307 | LYEL | Lyell Immunopharma, Inc. | 146.16M | 1.02% | 6,306 | 65.00K |
| 308 | ASMB | Assembly Biosciences, Inc. | 145.57M | 4.61% | 12,438 | 32.15M |
| 309 | THTX | Theratechnologies Inc. | 144.81M | - | 211,556 | 84.38M |
| 310 | ENTA | Enanta Pharmaceuticals, Inc. | 144.51M | -3.15% | 59,311 | 64.46M |
| 311 | IKT | Inhibikase Therapeutics, Inc. | 140.88M | -5.25% | 14,226 | 1.00 |
| 312 | RAPT | RAPT Therapeutics, Inc. | 138.41M | -2.90% | 8,798 | - |
| 313 | MOLN | Molecular Partners AG | 135.29M | 1.97% | 160 | 2.53M |
| 314 | FATE | Fate Therapeutics, Inc. | 131.25M | -1.29% | 340,217 | 13.34M |
| 315 | FBRX | Forte Biosciences, Inc. | 128.79M | -7.94% | 52,320 | - |
| 316 | ELTX | Elicio Therapeutics, Inc. | 128.74M | -2.60% | 9,737 | - |
| 317 | SKYE | Skye Bioscience, Inc. | 127.66M | 4.57% | 238,486 | - |
| 318 | GNLX | Genelux Corporation | 127.57M | -0.58% | 33,727 | 8.00K |
| 319 | NKTX | Nkarta, Inc. | 127.01M | -0.56% | 363,076 | - |
| 320 | VTVT | vTv Therapeutics Inc. | 125.68M | 0.23% | 1,227 | 17.00K |
| 321 | SEER | Seer, Inc. | 125.34M | -2.74% | 23,460 | 15.31M |
| 322 | KRRO | Korro Bio, Inc. | 120.67M | -5.45% | 26,439 | 4.82M |
| 323 | ATOS | Atossa Therapeutics, Inc. | 120.32M | 4.91% | 546,678 | - |
| 324 | ACTU | Actuate Therapeutics, Inc. | 120.17M | -0.89% | 8,119 | - |
| 325 | CSBR | Champions Oncology, Inc. | 119.38M | -1.14% | 2,261 | 58.59M |
| 326 | TARA | Protara Therapeutics, Inc. | 119.22M | -0.96% | 26,633 | - |
| 327 | SGMO | Sangamo Therapeutics, Inc. | 118.68M | -0.10% | 1,182,981 | 63.76M |
| 328 | ACHV | Achieve Life Sciences, Inc. | 117.82M | -1.72% | 119,686 | - |
| 329 | OBIO | Orchestra BioMed Holdings, Inc. | 114.75M | -0.17% | 60,061 | 2.89M |
| 330 | TNYA | Tenaya Therapeutics, Inc. | 113.87M | 1.77% | 975,964 | - |
| 331 | CLLS | Cellectis S.A. | 112.54M | - | 2,221 | 54.75M |
| 332 | PLX | Protalix BioTherapeutics, Inc. | 112.25M | -4.73% | 321,698 | 59.76M |
| 333 | HURA | TuHURA Biosciences, Inc. | 111.72M | -4.76% | 68,107 | - |
| 334 | BMEA | Biomea Fusion, Inc. | 110.05M | - | 306,515 | - |
| 335 | MIST | Milestone Pharmaceuticals Inc. | 109.19M | -35.74% | 13,287,297 | - |
| 336 | OKYO | OKYO Pharma Limited | 107.41M | 0.35% | 19,034 | - |
| 337 | MCRB | Seres Therapeutics, Inc. | 106.95M | -0.83% | 12,621 | - |
| 338 | ONCY | Oncolytics Biotech Inc. | 106.59M | 2.69% | 346,014 | - |
| 339 | HLVX | HilleVax, Inc. | 103.43M | -0.71% | 34,144 | - |
| 340 | COYA | Coya Therapeutics, Inc. | 103.36M | -2.29% | 25,485 | 3.69M |
| 341 | CHRS | Coherus Oncology, Inc. | 103.27M | 2.72% | 841,364 | 272.25M |
| 342 | SAVA | Cassava Sciences, Inc. | 103.14M | -1.16% | 188,025 | - |
| 343 | TCRX | TScan Therapeutics, Inc. | 102.71M | -1.36% | 84,391 | 4.42M |
| 344 | CTNM | Contineum Therapeutics, Inc. | 102.19M | -1.99% | 19,032 | - |
| 345 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 100.83M | -1.44% | 28,423 | - |
| 346 | ANIX | Anixa Biosciences, Inc. | 99.41M | -1.72% | 64,369 | - |
| 347 | MGNX | MacroGenics, Inc. | 98.42M | -1.27% | 299,911 | 154.05M |
| 348 | NAUT | Nautilus Biotechnology, Inc. | 94.66M | -0.21% | 137,298 | - |
| 349 | ZNTL | Zentalis Pharmaceuticals, Inc. | 94.26M | -4.38% | 297,258 | 26.87M |
| 350 | CLYM | Climb Bio, Inc. | 92.58M | 1.48% | 42,481 | - |
| 351 | ADAG | Adagene Inc. | 92.33M | 1.03% | 2,766 | 103.20K |
| 352 | WHWK | Whitehawk Therapeutics, Inc. | 91.86M | -1.02% | 64,978 | 27.78M |
| 353 | QNCX | Quince Therapeutics, Inc. | 91.16M | 12.64% | 231,534 | - |
| 354 | IOBT | IO Biotech, Inc. | 90.92M | -1.43% | 160,309 | - |
| 355 | NTHI | NeOnc Technologies Holdings, Inc. | 90.76M | -2.25% | 68,827 | 79.99K |
| 356 | NTRB | Nutriband Inc. | 90.20M | -1.17% | 26,040 | 2.40M |
| 357 | ATHE | Alterity Therapeutics Limited | 89.86M | 25.58% | 532,864 | 2.30M |
| 358 | BYSI | BeyondSpring Inc. | 89.50M | -1.33% | 103 | 1.88M |
| 359 | XBIT | XBiotech Inc. | 89.03M | -1.35% | 26,435 | - |
| 360 | VERU | Veru Inc. | 88.23M | 3.21% | 1,008,060 | 16.89M |
| 361 | IVVD | Invivyd, Inc. | 87.84M | -1.77% | 149,676 | 36.69M |
| 362 | OTLK | Outlook Therapeutics, Inc. | 87.21M | 0.74% | 757,750 | - |
| 363 | VXRT | Vaxart, Inc. | 86.64M | 9.41% | 942,353 | 47.40M |
| 364 | ORMP | Oramed Pharmaceuticals Inc. | 86.60M | - | 11,761 | 2.00M |
| 365 | PLRX | Pliant Therapeutics, Inc. | 86.54M | 0.70% | 286,553 | - |
| 366 | EXOZ | eXoZymes, Inc. | 83.89M | 0.05% | 3 | -700.00 |
| 367 | ZURA | Zura Bio Limited | 82.91M | -3.60% | 82,872 | - |
| 368 | VANI | Vivani Medical, Inc. | 82.65M | 9.84% | 185,514 | - |
| 369 | ABOS | Acumen Pharmaceuticals, Inc. | 82.08M | 4.23% | 488,611 | - |
| 370 | ENTX | Entera Bio Ltd. | 81.81M | -2.17% | 9,002 | 223.00K |
| 371 | IGMS | IGM Biosciences, Inc. | 81.56M | -0.37% | 63,807 | 2.68M |
| 372 | MGX | Metagenomi, Inc. | 80.74M | -2.26% | 425,187 | 45.26M |
| 373 | ARMP | Armata Pharmaceuticals, Inc. | 80.53M | -1.98% | 1,152 | 4.70M |
| 374 | CBUS | Cibus, Inc. | 79.66M | - | 119,200 | 4.75M |
| 375 | IMUX | Immunic, Inc. | 79.29M | -1.23% | 245,873 | - |
| 376 | CNTB | Connect Biopharma Holdings Limited | 77.79M | 21.74% | 202,664 | 26.03M |
| 377 | EPIX | ESSA Pharma Inc. | 76.35M | -1.71% | 11,943 | - |
| 378 | JUNS | Jupiter Neurosciences, Inc. | 75.31M | 19.11% | 740,586 | - |
| 379 | IMMX | Immix Biopharma, Inc. | 75.20M | -0.37% | 171,958 | - |
| 380 | SRZN | Surrozen, Inc. | 74.58M | 1.63% | 190 | 11.64M |
| 381 | GUTS | Fractyl Health, Inc. | 73.22M | -1.64% | 53,939 | 60.00K |
| 382 | PYXS | Pyxis Oncology, Inc. | 73.10M | -0.84% | 79,611 | 16.15M |
| 383 | VRCA | Verrica Pharmaceuticals Inc. | 73.00M | -9.54% | 181,116 | 7.18M |
| 384 | GNTA | Genenta Science S.p.A. | 72.79M | 2.05% | 795 | - |
| 385 | KLTO | Klotho Neurosciences, Inc. | 71.15M | -7.53% | 4,071,123 | - |
| 386 | INO | Inovio Pharmaceuticals, Inc. | 70.32M | -0.72% | 992,514 | 283.10K |
| 387 | ADAP | Adaptimmune Therapeutics plc | 69.52M | -4.37% | 207,928 | 179.64M |
| 388 | VTGN | Vistagen Therapeutics, Inc. | 69.40M | -2.06% | 89,720 | 486.00K |
| 389 | ANRO | Alto Neuroscience, Inc. | 69.31M | -0.77% | 23,398 | - |
| 390 | ANEB | Anebulo Pharmaceuticals, Inc. | 69.23M | -4.80% | 216 | - |
| 391 | CLSD | Clearside Biomedical, Inc. | 68.76M | 1.07% | 46,410 | 3.76M |
| 392 | IPA | ImmunoPrecise Antibodies Ltd. | 68.65M | -9.91% | 1,038,136 | 16.58M |
| 393 | RPTX | Repare Therapeutics Inc. | 66.27M | -0.96% | 12,469 | 1.07M |
| 394 | IRD | Opus Genetics, Inc. | 66.22M | -0.89% | 57,787 | 13.65M |
| 395 | ABVC | ABVC BioPharma, Inc. | 65.82M | 20.90% | 682,562 | 508.38K |
| 396 | STRO | Sutro Biopharma, Inc. | 65.71M | -4.87% | 51,304 | 66.43M |
| 397 | IKNA | Ikena Oncology, Inc. | 65.63M | -2.16% | 15,645 | - |
| 398 | QNTM | Quantum BioPharma Ltd. | 64.40M | -2.75% | 66,044 | - |
| 399 | PMVP | PMV Pharmaceuticals, Inc. | 63.90M | -3.15% | 38,199 | - |
| 400 | UNCY | Unicycive Therapeutics, Inc. | 63.71M | -4.00% | 299,788 | - |
| 401 | CRVO | CervoMed Inc. | 62.75M | - | 76,386 | 9.31M |
| 402 | MNOV | MediciNova, Inc. | 62.29M | - | 9,442 | - |
| 403 | INMB | INmune Bio, Inc. | 62.21M | 4.93% | 572,331 | 50.00K |
| 404 | CNTX | Context Therapeutics Inc. | 61.00M | 1.48% | 22,967 | - |
| 405 | ACET | Adicet Bio, Inc. | 60.08M | -1.81% | 154,417 | - |
| 406 | IFRX | InflaRx N.V. | 59.63M | -1.68% | 125,886 | 140.24K |
| 407 | PDSB | PDS Biotechnology Corporation | 58.05M | -2.31% | 236,600 | - |
| 408 | APLT | Applied Therapeutics, Inc. | 58.05M | -0.99% | 611,462 | 265.00K |
| 409 | ICCC | ImmuCell Corporation | 57.75M | -1.99% | 407 | 27.30M |
| 410 | SNTI | Senti Biosciences, Inc. | 57.64M | -4.74% | 19,976 | - |
| 411 | ANL | Adlai Nortye Ltd. | 57.01M | 2.32% | 225 | 1.94M |
| 412 | MAIA | MAIA Biotechnology, Inc. | 56.37M | -3.63% | 114,661 | - |
| 413 | ATRA | Atara Biotherapeutics, Inc. | 56.24M | -0.48% | 8,180 | 199.73M |
| 414 | NRXP | NRx Pharmaceuticals, Inc. | 56.19M | -0.61% | 83,925 | - |
| 415 | SER | Serina Therapeutics, Inc. | 55.32M | -5.87% | 1,751 | 51.00K |
| 416 | FBIO | Fortress Biotech, Inc. | 55.02M | -6.50% | 221,548 | 57.78M |
| 417 | ANVS | Annovis Bio, Inc. | 54.76M | -1.40% | 131,296 | - |
| 418 | HOWL | Werewolf Therapeutics, Inc. | 54.75M | 12.96% | 172,301 | 1.14M |
| 419 | IPSC | Century Therapeutics, Inc. | 53.50M | 0.44% | 417,548 | 114.90M |
| 420 | ADVM | Adverum Biotechnologies, Inc. | 53.38M | -6.07% | 26,598 | 1.00M |
| 421 | CUE | Cue Biopharma, Inc. | 53.12M | -11.43% | 59,395 | 7.99M |
| 422 | JSPR | Jasper Therapeutics, Inc. | 51.98M | -2.54% | 232,267 | - |
| 423 | AVTX | Avalo Therapeutics, Inc. | 51.86M | -2.24% | 16,528 | 441.00K |
| 424 | GANX | Gain Therapeutics, Inc. | 51.43M | -1.69% | 38,021 | - |
| 425 | CELU | Celularity Inc. | 51.01M | -1.39% | 35,569 | 54.22M |
| 426 | DTIL | Precision BioSciences, Inc. | 50.99M | -4.80% | 102,252 | 51.14M |
| 427 | ALGS | Aligos Therapeutics, Inc. | 50.94M | -5.23% | 15,332 | 3.27M |
| 428 | NRSN | NeuroSense Therapeutics Ltd. | 50.38M | -0.47% | 81,833 | - |
| 429 | OSTX | OS Therapies Incorporated | 49.55M | - | 192,539 | - |
| 430 | RNXT | RenovoRx, Inc. | 48.64M | -0.75% | 9,989 | 240.00K |
| 431 | KLRS | Kalaris Therapeutics, Inc. | 48.63M | 4.00% | 6,951 | - |
| 432 | PRLD | Prelude Therapeutics Incorporated | 48.39M | -3.38% | 59,992 | 7.00M |
| 433 | RENB | Renovaro Inc. | 48.09M | -5.99% | 604,513 | - |
| 434 | ATNM | Actinium Pharmaceuticals, Inc. | 47.11M | -2.58% | 106,878 | 81.00K |
| 435 | ITRM | Iterum Therapeutics plc | 46.80M | 8.33% | 1,297,151 | - |
| 436 | XCUR | Exicure, Inc. | 46.40M | 0.89% | 5,367 | 500.00K |
| 437 | ARTV | Artiva Biotherapeutics, Inc. | 46.29M | 6.15% | 350,278 | 251.00K |
| 438 | MRSN | Mersana Therapeutics, Inc. | 45.12M | -4.74% | 1,651,550 | 34.01M |
| 439 | GRCE | Grace Therapeutics, Inc. | 43.59M | 1.69% | 15,941 | - |
| 440 | PLUR | Pluri Inc. | 42.43M | -0.37% | 1,456 | 1.03M |
| 441 | MURA | Mural Oncology plc | 42.31M | -1.41% | 18,577 | - |
| 442 | ACRV | Acrivon Therapeutics, Inc. | 41.39M | -2.22% | 34,595 | - |
| 443 | BRNS | Barinthus Biotherapeutics plc | 40.34M | -5.66% | 3,427 | 14.97M |
| 444 | PEPG | PepGen Inc. | 40.03M | -2.14% | 52,508 | - |
| 445 | KALA | KALA BIO, Inc. | 39.30M | -11.74% | 64,868 | - |
| 446 | LTRN | Lantern Pharma Inc. | 38.77M | 2.42% | 116,045 | - |
| 447 | CGTX | Cognition Therapeutics, Inc. | 38.56M | -11.10% | 5,100,553 | - |
| 448 | RANI | Rani Therapeutics Holdings, Inc. | 38.54M | 1.44% | 50,252 | 1.20M |
| 449 | XLO | Xilio Therapeutics, Inc. | 37.55M | -2.51% | 116,573 | 9.27M |
| 450 | STTK | Shattuck Labs, Inc. | 37.47M | 1.02% | 42,948 | 4.61M |
| 451 | AKTX | Akari Therapeutics, Plc | 36.36M | -1.31% | 9,786 | - |
| 452 | LVTX | LAVA Therapeutics N.V. | 35.25M | -0.75% | 2,477 | 4.99M |
| 453 | PYPD | PolyPid Ltd. | 35.06M | -0.86% | 30,172 | - |
| 454 | QTTB | Q32 Bio Inc. | 34.89M | -13.86% | 2,999,718 | - |
| 455 | TELO | Telomir Pharmaceuticals, Inc. | 34.52M | -0.85% | 100,696 | - |
| 456 | OKUR | OnKure Therapeutics, Inc. | 34.18M | -0.78% | 30,960 | - |
| 457 | RADX | Radiopharm Theranostics Limited | 34.15M | 0.48% | 9,856 | 204.61K |
| 458 | KPTI | Karyopharm Therapeutics Inc. | 33.70M | -22.00% | 582,028 | 142.13M |
| 459 | RNTX | Rein Therapeutics Inc. | 33.56M | 2.36% | 2,685 | - |
| 460 | COEP | Coeptis Therapeutics Holdings, Inc. | 32.89M | -1.47% | 11,443 | 62.87K |
| 461 | KZR | Kezar Life Sciences, Inc. | 32.51M | -7.10% | 82 | - |
| 462 | ENLV | Enlivex Therapeutics Ltd. | 32.21M | 1.49% | 20,770 | - |
| 463 | IGC | IGC Pharma, Inc. | 31.85M | -8.51% | 4,003,612 | 1.27M |
| 464 | ANTX | AN2 Therapeutics, Inc. | 31.74M | -1.70% | 23,649 | - |
| 465 | ESLA | Estrella Immunopharma, Inc. | 31.16M | -6.74% | 1,043 | - |
| 466 | CAMP | Camp4 Therapeutics Corporation | 30.74M | -0.97% | 10,435 | 1.51M |
| 467 | FGEN | FibroGen, Inc. | 29.87M | 0.54% | 39,194 | 7.00M |
| 468 | DYAI | Dyadic International, Inc. | 29.50M | -1.94% | 15,824 | 3.55M |
| 469 | TPST | Tempest Therapeutics, Inc. | 29.31M | -2.58% | 42,332 | - |
| 470 | OVID | Ovid Therapeutics Inc. | 29.29M | -1.69% | 347,199 | 548.00K |
| 471 | CLDI | Calidi Biotherapeutics, Inc. | 28.90M | -13.81% | 7,026,988 | - |
| 472 | CALC | CalciMedica, Inc. | 27.52M | 21.60% | 156,643 | - |
| 473 | GBIO | Generation Bio Co. | 26.59M | 6.38% | 595,714 | 24.56M |
| 474 | BOLD | Boundless Bio, Inc. | 26.41M | - | 40,750 | - |
| 475 | CVM | CEL-SCI Corporation | 26.29M | 34.03% | 21,515,064 | - |
| 476 | PBM | Psyence Biomedical Ltd. | 26.02M | -1.83% | 3,189 | - |
| 477 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 25.93M | -2.73% | 1,376,905 | - |
| 478 | ALXO | ALX Oncology Holdings Inc. | 25.71M | -3.22% | 106,139 | - |
| 479 | GDTC | CytoMed Therapeutics Limited | 25.50M | 0.45% | 1,045 | 368.84K |
| 480 | FBLG | FibroBiologics, Inc. | 25.04M | -1.68% | 117,377 | - |
| 481 | CVKD | Cadrenal Therapeutics, Inc. | 24.94M | -2.46% | 15,163 | - |
| 482 | PASG | Passage Bio, Inc. | 24.91M | 0.83% | 153,771 | - |
| 483 | NRXS | NeurAxis, Inc. | 24.10M | 4.98% | 51,382 | 2.93M |
| 484 | SABS | SAB Biotherapeutics, Inc. | 23.97M | 3.20% | 23,778 | 377.84K |
| 485 | OSRH | OSR Holdings, Inc. | 23.52M | 0.83% | 75,297 | -148.95K |
| 486 | PULM | Pulmatrix, Inc. | 23.28M | -1.01% | 2,382 | 1.92M |
| 487 | PTIX | Protagenic Therapeutics, Inc. | 23.05M | -0.06% | 172,284 | - |
| 488 | SLGL | Sol-Gel Technologies Ltd. | 22.81M | 0.98% | 714 | 12.10M |
| 489 | DARE | Daré Bioscience, Inc. | 22.75M | 7.53% | 7,594,616 | 25.91K |
| 490 | ELEV | Elevation Oncology, Inc. | 22.50M | 0.32% | 204,089 | - |
| 491 | VYNE | VYNE Therapeutics Inc. | 22.50M | -2.17% | 167,548 | 605.00K |
| 492 | BCAB | BioAtla, Inc. | 22.49M | -0.41% | 514,860 | 11.00M |
| 493 | LGVN | Longeveron Inc. | 22.44M | -0.33% | 217,553 | 2.23M |
| 494 | CMMB | Chemomab Therapeutics Ltd. | 22.42M | 0.86% | 44,792 | - |
| 495 | LSTA | Lisata Therapeutics, Inc. | 22.23M | -5.66% | 6,208 | 1.00M |
| 496 | NNVC | NanoViricides, Inc. | 22.18M | -2.13% | 38,454 | - |
| 497 | RLMD | Relmada Therapeutics, Inc. | 21.64M | -2.70% | 15,113 | - |
| 498 | MLEC | Moolec Science SA | 20.87M | -9.88% | 12,485 | 7.83M |
| 499 | APUS | Apimeds Pharmaceuticals US, Inc. | 20.84M | -0.55% | 7,167 | - |
| 500 | CASI | CASI Pharmaceuticals, Inc. | 20.81M | -6.05% | 3,649 | 31.37M |
| 501 | LSB | LakeShore Biopharma Co., Ltd | 20.42M | - | 93,813 | 79.42M |
| 502 | BLRX | BioLineRx Ltd. | 20.05M | -1.74% | 23,822 | 22.34M |
| 503 | CRIS | Curis, Inc. | 20.02M | -0.85% | 658,868 | 11.20M |
| 504 | MRKR | Marker Therapeutics, Inc. | 19.35M | -5.00% | 75,815 | 5.70M |
| 505 | HOTH | Hoth Therapeutics, Inc. | 19.29M | -2.01% | 315,579 | - |
| 506 | CING | Cingulate Inc. | 18.51M | -1.58% | 64,503 | - |
| 507 | ARTL | Artelo Biosciences, Inc. | 18.29M | -6.14% | 114,621 | - |
| 508 | COCP | Cocrystal Pharma, Inc. | 18.21M | 14.01% | 83,742 | - |
| 509 | CTXR | Citius Pharmaceuticals, Inc. | 18.10M | -0.61% | 174,199 | - |
| 510 | MEIP | MEI Pharma, Inc. | 17.89M | -0.19% | 8,537 | - |
| 511 | PSTV | Plus Therapeutics, Inc. | 17.85M | -0.28% | 2,835,358 | 5.21M |
| 512 | CLGN | CollPlant Biotechnologies Ltd. | 17.74M | -1.06% | 1,099 | 2.47M |
| 513 | LEXX | Lexaria Bioscience Corp. | 17.53M | -0.06% | 38,822 | 525.92K |
| 514 | LPCN | Lipocine Inc. | 17.28M | -2.71% | 20,119 | 3.67M |
| 515 | SONN | Sonnet BioTherapeutics Holdings, Inc. | 17.13M | 2.46% | 352,103 | 1.00M |
| 516 | EVAX | Evaxion A/S | 17.11M | 5.02% | 277,057 | 3.29M |
| 517 | ATHA | Athira Pharma, Inc. | 16.99M | 3.37% | 85,547 | - |
| 518 | PTHS | Pelthos Therapeutics Inc. | 16.65M | -4.68% | 75,749 | - |
| 519 | ASBP | Aspire Biopharma Holdings, Inc. | 16.63M | -1.82% | 909,361 | - |
| 520 | CARM | Carisma Therapeutics, Inc. | 16.55M | -0.50% | 419,029 | 19.96M |
| 521 | RLYB | Rallybio Corporation | 16.15M | -2.02% | 393,423 | 848.00K |
| 522 | CANF | Can-Fite BioPharma Ltd. | 15.62M | - | 22,740 | 674.00K |
| 523 | GOVX | GeoVax Labs, Inc. | 15.33M | -0.36% | 440,932 | 5.59M |
| 524 | HOOK | HOOKIPA Pharma Inc. | 15.27M | -2.03% | 20,226 | 9.35M |
| 525 | ALLR | Allarity Therapeutics, Inc. | 15.15M | -6.94% | 220,133 | - |
| 526 | LPTX | Leap Therapeutics, Inc. | 14.55M | -1.15% | 131,727 | - |
| 527 | ERNA | Ernexa Therapeutics Inc. | 14.50M | -0.51% | 3,025 | 535.00K |
| 528 | EDSA | Edesa Biotech, Inc. | 14.40M | -0.97% | 2,273 | - |
| 529 | NEUP | Neuphoria Therapeutics Inc. | 14.19M | -0.71% | 19,379 | 15.66M |
| 530 | SYBX | Synlogic, Inc. | 14.07M | -2.97% | 168 | 8.00K |
| 531 | MTVA | MetaVia Inc. | 14.01M | -0.42% | 19,447 | - |
| 532 | BCTX | BriaCell Therapeutics Corp. | 13.86M | 0.48% | 931,737 | - |
| 533 | LYRA | Lyra Therapeutics, Inc. | 13.68M | -5.52% | 24,750 | 1.19M |
| 534 | BIVI | BioVie Inc. | 13.65M | - | 28,434 | - |
| 535 | IMNN | Imunon, Inc. | 13.58M | -1.92% | 395,256 | - |
| 536 | PRTG | Portage Biotech Inc. | 13.56M | -2.78% | 5,126 | - |
| 537 | MBRX | Moleculin Biotech, Inc. | 13.49M | 4.85% | 1,762,630 | - |
| 538 | PMN | ProMIS Neurosciences, Inc. | 13.30M | 1.12% | 34,646 | - |
| 539 | XTLB | XTL Biopharmaceuticals Ltd. | 13.29M | - | 2,229 | 451.00K |
| 540 | IBIO | iBio, Inc. | 12.91M | -3.53% | 199,611 | 375.00K |
| 541 | MBIO | Mustang Bio, Inc. | 12.71M | 8.40% | 952,488 | - |
| 542 | EVGN | Evogene Ltd. | 12.58M | -3.45% | 41,132 | 6.77M |
| 543 | EQ | Equillium, Inc. | 12.50M | 0.52% | 150,639 | 30.41M |
| 544 | NXTC | NextCure, Inc. | 12.49M | -4.93% | 49,029 | - |
| 545 | TAOX | TAO Synergies Inc. | 12.39M | 11.53% | 751,339 | - |
| 546 | BCDA | BioCardia, Inc. | 12.27M | -2.07% | 61,596 | 3.00K |
| 547 | BRTX | BioRestorative Therapies, Inc. | 12.16M | 1.26% | 5,525 | 391.00K |
| 548 | BTAI | BioXcel Therapeutics, Inc. | 11.99M | -1.00% | 70,420 | 1.85M |
| 549 | ABP | Abpro Holdings, Inc. | 11.88M | 0.41% | 777,895 | 183.00K |
| 550 | BOLT | Bolt Biotherapeutics, Inc. | 11.87M | -2.06% | 2,698 | 3.64M |
| 551 | BCLI | Brainstorm Cell Therapeutics Inc. | 11.86M | -1.23% | 125,944 | - |
| 552 | KAPA | Kairos Pharma, Ltd. | 11.81M | -1.38% | 136,926 | - |
| 553 | CYCN | Cyclerion Therapeutics, Inc. | 11.49M | 0.85% | 16,479 | 2.08M |
| 554 | ACXP | Acurx Pharmaceuticals, Inc. | 11.46M | -2.20% | 158,312 | - |
| 555 | KZIA | Kazia Therapeutics Limited | 11.36M | -1.93% | 55,973 | 1.55M |
| 556 | NERV | Minerva Neurosciences, Inc. | 11.33M | -1.22% | 1,562 | - |
| 557 | PHIO | Phio Pharmaceuticals Corp. | 11.09M | -5.44% | 81,639 | - |
| 558 | CSCI | COSCIENS Biopharma Inc. | 10.99M | -5.70% | 2,509 | 9.03M |
| 559 | APVO | Aptevo Therapeutics Inc. | 10.97M | -1.66% | 43,578 | - |
| 560 | LIXT | Lixte Biotechnology Holdings, Inc. | 10.95M | -5.92% | 376,900 | - |
| 561 | PHGE | BiomX Inc. | 10.81M | 0.76% | 30,607 | - |
| 562 | SNSE | Sensei Biotherapeutics, Inc. | 10.73M | -6.48% | 848 | - |
| 563 | IMRN | Immuron Limited | 10.29M | -0.84% | 2,302 | 4.05M |
| 564 | APRE | Aprea Therapeutics, Inc. | 9.93M | 1.41% | 4,478 | 1.28M |
| 565 | ICU | SeaStar Medical Holding Corporation | 9.74M | -1.71% | 2,022,030 | 428.00K |
| 566 | AEON | AEON Biopharma, Inc. | 9.73M | 0.06% | 59,970 | - |
| 567 | TCRT | Alaunos Therapeutics, Inc. | 9.67M | -0.88% | 3,615 | 11.00K |
| 568 | KPRX | Kiora Pharmaceuticals, Inc. | 9.44M | 3.03% | 38,602 | 20.00K |
| 569 | DWTX | Dogwood Therapeutics, Inc. | 9.21M | -3.40% | 4,938 | - |
| 570 | CLRB | Cellectar Biosciences, Inc. | 8.87M | -0.71% | 31,999 | - |
| 571 | TRAW | Traws Pharma, Inc. | 8.62M | -1.27% | 24,854 | 227.00K |
| 572 | XFOR | X4 Pharmaceuticals, Inc. | 8.60M | -5.41% | 193,107 | 31.36M |
| 573 | TSBX | Turnstone Biologics Corp. | 8.37M | -1.79% | 30,636 | - |
| 574 | INTS | Intensity Therapeutics, Inc. | 8.07M | 1.74% | 2,607,880 | - |
| 575 | GNPX | Genprex, Inc. | 8.03M | -4.81% | 251,505 | - |
| 576 | INAB | IN8bio, Inc. | 7.78M | -1.31% | 67,333 | - |
| 577 | PMCB | PharmaCyte Biotech, Inc. | 7.77M | 3.10% | 5,254 | - |
| 578 | CELZ | Creative Medical Technology Holdings, Inc. | 7.70M | 4.01% | 739,694 | 14.00K |
| 579 | ADXN | Addex Therapeutics Ltd | 7.62M | -1.23% | 1,215 | 278.51K |
| 580 | THAR | Tharimmune, Inc. | 7.50M | 0.56% | 9,554 | - |
| 581 | CDIO | Cardio Diagnostics Holdings, Inc. | 7.25M | -2.80% | 6,728 | 19.90K |
| 582 | INDP | Indaptus Therapeutics, Inc. | 7.20M | 1.94% | 6,186 | - |
| 583 | RNAZ | TransCode Therapeutics, Inc. | 7.19M | -4.11% | 14,026 | - |
| 584 | GTBP | GT Biopharma, Inc. | 7.13M | -1.09% | 36,968 | - |
| 585 | IBO | Impact BioMedical Inc. | 7.01M | 1.29% | 215,427 | - |
| 586 | PPBT | Purple Biotech Ltd | 6.85M | -1.19% | 4,641 | - |
| 587 | SLXN | Silexion Therapeutics Corp | 6.73M | -3.14% | 168,051 | - |
| 588 | NLSP | NLS Pharmaceutics AG | 6.72M | -5.00% | 87,829 | - |
| 589 | APM | Aptorum Group Limited | 6.71M | 1.04% | 23,068 | - |
| 590 | APLM | Apollomics, Inc. | 6.19M | -1.58% | 10,713 | 198.00K |
| 591 | CYCC | Cyclacel Pharmaceuticals, Inc. | 6.05M | -9.05% | 35,236 | 14.00K |
| 592 | ADIL | Adial Pharmaceuticals, Inc. | 6.04M | -6.56% | 1,236,450 | - |
| 593 | XBIO | Xenetic Biosciences, Inc. | 6.03M | 2.07% | 15,117 | 2.58M |
| 594 | QLGN | Qualigen Therapeutics, Inc. | 5.87M | 1.99% | 4,062 | - |
| 595 | PCSA | Processa Pharmaceuticals, Inc. | 5.83M | -3.22% | 2,397,330 | - |
| 596 | HCWB | HCW Biologics Inc. | 5.68M | -2.71% | 9,778 | 1.45M |
| 597 | CDT | Conduit Pharmaceuticals Inc. | 5.68M | -2.07% | 68,104 | - |
| 598 | QNRX | Quoin Pharmaceuticals, Ltd. | 5.30M | - | 296 | - |
| 599 | MTNB | Matinas BioPharma Holdings, Inc. | 5.21M | -0.51% | 44,939 | - |
| 600 | KTTA | Pasithea Therapeutics Corp. | 5.13M | -0.14% | 30,710 | - |
| 601 | ATNF | 180 Life Sciences Corp. | 5.08M | 0.79% | 22,583 | - |
| 602 | TTNP | Titan Pharmaceuticals, Inc. | 5.04M | -1.84% | 8,140 | - |
| 603 | CMND | Clearmind Medicine Inc. | 4.98M | -1.02% | 105,692 | - |
| 604 | VIVS | VivoSim Labs, Inc. | 4.97M | -3.05% | 6,277 | 144.00K |
| 605 | CNSP | CNS Pharmaceuticals, Inc. | 4.78M | -3.63% | 69,285 | - |
| 606 | SILO | Silo Pharma, Inc. | 4.69M | 3.44% | 408,467 | 72.10K |
| 607 | DRMA | Dermata Therapeutics, Inc. | 4.66M | 1.43% | 132,708 | - |
| 608 | GLMD | Galmed Pharmaceuticals Ltd. | 4.47M | -2.46% | 125,710 | - |
| 609 | GLTO | Galecto, Inc. | 4.44M | -3.17% | 46,518 | - |
| 610 | TOVX | Theriva Biologics, Inc. | 4.29M | 0.72% | 87,055 | - |
| 611 | SNGX | Soligenix, Inc. | 4.08M | -1.57% | 75,074 | 2.34K |
| 612 | AZTR | Azitra, Inc. | 4.05M | -6.97% | 269,093 | 7.50K |
| 613 | NBY | NovaBay Pharmaceuticals, Inc. | 4.02M | 6.36% | 41,782 | 9.78M |
| 614 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 3.86M | 0.38% | 29,267 | 802.32K |
| 615 | VRAX | Virax Biolabs Group Limited | 3.85M | -0.47% | 6,138 | 6.33K |
| 616 | ENSC | Ensysce Biosciences, Inc. | 3.78M | 10.05% | 32,150 | 6.22M |
| 617 | PLRZ | Polyrizon Ltd. | 3.76M | -1.56% | 62,306 | - |
| 618 | SPRC | SciSparc Ltd. | 3.70M | 0.22% | 5,730 | 1.31M |
| 619 | JAGX | Jaguar Health, Inc. | 3.68M | 5.70% | 93,724 | 11.55M |
| 620 | GRI | GRI Bio, Inc. | 3.66M | -1.35% | 47,012 | - |
| 621 | PALI | Palisade Bio, Inc. | 3.60M | -3.83% | 26,745 | - |
| 622 | CERO | CERo Therapeutics Holdings, Inc. | 3.28M | -3.95% | 32,847 | - |
| 623 | ENVB | Enveric Biosciences, Inc. | 3.26M | -2.22% | 39,566 | - |
| 624 | XRTX | XORTX Therapeutics Inc. | 3.15M | 5.75% | 15,646 | - |
| 625 | ELAB | PMGC Holdings Inc. | 3.08M | -1.32% | 21,530 | 2.45M |
| 626 | ZVSA | ZyVersa Therapeutics, Inc. | 2.79M | -3.08% | 666,794 | - |
| 627 | WINT | Windtree Therapeutics, Inc. | 2.59M | 8.92% | 1,555,541 | - |
| 628 | ADTX | Aditxt, Inc. | 2.57M | -0.82% | 151,159 | 55.32K |
| 629 | BDRX | Biodexa Pharmaceuticals Plc | 2.55M | -0.96% | 55,619 | 104.90K |
| 630 | ALZN | Alzamend Neuro, Inc. | 2.31M | 3.28% | 268,705 | - |
| 631 | ENTO | Entero Therapeutics, Inc. | 2.27M | -2.38% | 157,625 | - |
| 632 | ONCO | Onconetix, Inc. | 2.24M | -1.83% | 36,430 | 1.93M |
| 633 | SCNI | Scinai Immunotherapeutics Ltd. | 2.06M | -3.91% | 15,117 | 658.00K |
| 634 | REVB | Revelation Biosciences, Inc. | 1.89M | -0.88% | 100,653 | - |
| 635 | UBX | Unity Biotechnology, Inc. | 1.74M | -36.88% | 1,010,722 | - |
| 636 | TNFA | TNF Pharmaceuticals, Inc. | 1.58M | -4.53% | 2,314,981 | - |
| 637 | SLRX | Salarius Pharmaceuticals, Inc. | 1.58M | -4.75% | 87,042 | - |
| 638 | OGEN | Oragenics, Inc. | 1.12M | -6.85% | 191,866 | - |
| 639 | NCNA | NuCana plc | 311.93K | -13.74% | 136,156,028 | - |